Welcome

Advances in breast cancer testing and treatment have greatly improved patient outcomes. Knowing a woman's HER2 status is an essential component to understanding how to treat breast cancer and potentially extend survival. 

This web site will provide you with an overview of the HER2 testing options currently available and why studies have consistently shown that the PathVysion HER2 test, which employs FISH technology, is superior over other testing methods to accurately and reproducibly assess a woman's tumor for
HER-2 status.